What is molecular targeted therapy?
Molecular targeted therapy is the treatment of cancer that attacks specific molecules. This highly specific treatment interrupts the cell division process to stop proliferation of cancer cells inside the patient. Numerous cancer medicines use this technique and pharmaceutical companies are constantly evolving to expand the arsenal of therapeutic options. In some cases, research and development of the therapy may take over ten years. These molecules can be inside or outside cells. Scientists can use tools such as comprehensive chemical analysis, DNA sequencing, and cell research in culture to find molecules connected to specific cancer. They are looking for unique molecules that have not been found elsewhere in the body to concentrate on these structures in treatment and avoid damage to healthy tissues.
As soon as scientists have a target, de Develop can be drugs that connect to a given molecule. This may include medicines that work on molecular levels inside the cell as well as monoclonal antibodies that may attach tot on the molecules found on the cell surface. At this stage of development, scientists working on molecular targeted therapy must be able to reliably determine the required molecules without hanging other tissues. If a chemical compound appears to be promising, it can start testing to see how it works in living organisms.
Many drugs fail on the way because they do not work, cause unacceptable side effects or unexpectedly perform. Once molecular targeted therapy is cleaned for use, it can be prescribed for cancer patients within the treatment plan. The doctor may recommend surgery in an effort to remove as many cancer cells as possible, usually followed by chemotherapy in the fight against the remaining cancer. Tmolecular targeted therapy limits the chance of relapse by stopping uncontrolled cell growth and preventing cancer.
These drugs can be highly specific. Molecular targeted therapy beginsResearch by specific types of cancer to find rogue molecules that can create good goals, which means that drugs are not useful for chemotherapy of a wide range. For example, a drug developed for the treatment of brain cancer may not have any effect on lung cancer because the molecular structure of the disease is different. Scientists work with a range of cancer and tend to focus on those that are most common in the process of developing new treatments.